40-Hz steady state response in Alzheimer's disease and mild cognitive impairment

Neurobiology of Aging

Volumn 32, Issue 1, 2011, Pages 24-30

  van Deursen, J A ^a,b   Vuurman, E F P M ^a,b   van Kranen Mastenbroek, V H J M ^c   Verhey, F R J ^a   Riedel, W J ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

40 Hz; Alzheimer's disease; Cortical inhibition; EEG; MCI; Neurophysiology; Reliability; Steady state response

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; AUDITORY STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; FEMALE; FREQUENCY MODULATION; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; STEADY STATE; STIMULUS RESPONSE; TEST RETEST RELIABILITY;

ACOUSTIC STIMULATION; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; REPRODUCIBILITY OF RESULTS;

EID: 78449277546     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.01.002     Document Type: Article

References (39)

1. Ahveninen J., Jaaskelainen I.P., Kaakkola S., Tiitinen H., Pekkonen E. Aging and cholinergic modulation of the transient magnetic 40-Hz auditory response. Neuroimage 2002, 15(1):153-158.
2. Ahveninen J., Tiitinen H., Hirvonen J., Pekkonen E., Huttunen J., Kaakkola S., Jaaskelainen I.P. Scopolamine augments transient auditory 40-Hz magnetic response in humans. Neurosci Lett. 1999, 277(2):115-118.
3. Blessed G., Tomlinson B.E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br. J. Psychiatry 1968, 114(512):797-811.
4. Boutros N., Torello M.W., Burns E.M., Wu S.S., Nasrallah H.A. Evoked potentials in subjects at risk for Alzheimer's disease. Psychiatry Res. 1995, 57(1):57-63.
5. Braak H., Braak A. Staging Of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 1995, 16(3):271-284.
6. Brinkmeyer J., Grass-Kapanke B., Ihl R. EEG and the test for the early detection of dementia with discrimination from depression (TE4D): a validation study. Int. J. Geriatr. Psychiatry 2004, 19(8):749-753.
7. Cancelli I., Cadore I.P., Merlino G., Valentinis L., Moratti U., Bergonzi P., Gigli G.L., Valente M. Sensory gating deficit assessed by P50/Pb middle latency event related potential in Alzheimer's disease. J. Clin. Neurophysiol. 2006, 23(5):421-425.
8. Derix M.M., Hofstede A.B., Teunisse S., Hijdra A., Walstra G.J., Weinstein H.C., van Gool W.A. CAMDEX-N: the Dutch version of the Cambridge examination for mental disorders of the elderly with automatic data processing. Tijdschr. Gerontol. Geriatr. 1991, 22(4):143-150.
9. Folstein N., Folstein S., McHugh P. Mini-mental state: a practical method for grading the cognitive state of patients for clinician. J. Psychiatry Res. 1975, 12:189-198.
10. Francis P.T. Glutamatergic systems in Alzheimer's disease. Int. J. Geriatr. Psychiatry 2003, 18(Suppl. 1):S15-21.
11. Galambos R., Makeig S., Talmachoff P.J. A 40-Hz auditory potential recorded from the human scalp. Proc. Natl. Acad. Sci. U.S.A. 1981, 78(4):2643-2647.
12. Garcia-Alloza M., Tsang S.W., Gil-Bea F.J., Francis P.T., Lai M.K., Marcos B., Chen C.P., Ramirez M.J. Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease. Neurobiol. Aging 2006, 27(8):1110-1117.
13. Gutschalk A., Mase R., Roth R., Ille N., Rupp A., Hahnel S., Picton T.W., Scherg M. Deconvolution of 40Hz steady-state fields reveals two overlapping source activities of the human auditory cortex. Clin. Neurophysiol. 1999, 110(5.):856-868.
14. Hamilton M. A rating scale for depression. J. Neurol., Neurosur., Psychiatry 1960, 23:56-62.
15. Herrmann C.S., Munk M.H., Engel A.K. Cognitive functions of gamma-band activity: memory match and utilization. Trends Cogn. Sci. 2004, 8(8):347-355.
16. Huang C., Wahlund L., Dierks O., Julin T., Winblad P., Jelic B.B. Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study. Clin. Neurophysiol. 2000, 111:1961-1967.
17. Jaaskelainen I.P., Hirvonen J., Saher M., Pekkonen E., Sillanaukee P., Naatanen R., Tiitinen H. Benzodiazepine temazepam suppresses the transient auditory 40-Hz response amplitude in humans. Neurosci. Lett. 1999, 268(2):105-107.
18. Jacob T.C., Moss S.J., Jurd R. GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition. Nat. Rev. Neurosci. 2008, 9(5):331-343.
19. Jessen F., Kucharski C., Fries T., Papassotiropoulos A., Hoenig K., Maier W., Heun R. Sensory gating deficit expressed by a disturbed suppression of the P50 event-related potential in patients with Alzheimer's disease. Am. J. Psychiatry 2001, 158(8):1319-1321.
20. Joliot M., Ribary U., Llinas R. Human oscillatory brain activity near 40Hz coexists with cognitive temporal binding. Proc. Natl. Acad. Sci. U.S.A. 1994, 91(24):11748-11751.
21. Karakas S., Basar E. Early gamma response is sensory in origin: a conclusion based on cross-comparison of results from multiple experimental paradigms. Int. J. Psychophysiol. 1998, 31(1):13-31.
22. Lanctot K.L., Herrmann N., Mazzotta P., Khan L.R., Ingber N. GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia. Can. J. Psychiatry 2004, 49(7):439-453.
23. Lowe S.L., Francis P.T., Procter A.W., Palmer A.M., Davison A.N., Bowen D.M. Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease. Brain 1988, 111(Pt. 4):785-799.
24. Luckhaus C., Grass-Kapanke B., Blaeser I., Ihl R., Supprian T., Winterer G., Zielasek J., Brinkmeyer J., et al. Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study. Int. J. Geriatr. Psychiatry 2008, 23(11):1148-1155.
25. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984, 34(7):939-944.
26. Osipova D., Pekkonen E., Ahveninen J. Enhanced magnetic auditory steady-state response in early Alzheimer's disease. Clin. Neurophysiol. 2006, 117(9):1990-1995.
27. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Int. Med. 2004, 256(3):183-194.
28. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., Winblad B. Current concepts in mild cognitive impairment. Arch. Neurol. 2001, 8(12):1985-1992.
29. Reisberg B., Ferris S.H., de Leon M.J., Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatry 1982, 139(9):1136-1139.
30. Ribary U., Ioannides A.A., Singh K.D., Hasson R., Bolton J.P., Lado F., Mogilner A., Llinas R. Magnetic field tomography of coherent thalamocortical 40-Hz oscillations in humans. Proc. Natl. Acad. Sci. U.S.A. 1991, 88(24):11037-11041.
31. Rosen W.G., Mohs R.C., Davis K.L. A new rating scale for Alzheimer's disease. Am. J. Psychiatry 1984, 141(11):1356-1364.
32. Schmand B., Geerlings M.I., Jonker C., Lindeboom J. Reading ability as an estimator of premorbid intelligence: does it remain stable in emergent dementia?. J. Clin. Exp. Neuropsychol. 1998, 20(1):42-51.
33. Tallon-Baudry C., Bertrand O. Oscillatory gamma activity in humans and its role in object representation. Trends Cogn. Sci. 1999, 3(4):151-162.
34. van Boxtel M.P., Buntinx F., Houx P.J., Metsemakers J.F., Knottnerus A., Jolles J. The relation between morbidity and cognitive performance in a normal aging population. J. Gerontol. 1998, 53(2):M147-M154.
35. van Deursen J.A., Vuurman E.F., Verhey F.R., van Kranen-Mastenbroek V.H., Riedel W.J. Increased EEG gamma band activity in Alzheimer's disease and mild cognitive impairment. J. Neural. Transm. 2008, 115(9):1301-1311.
36. Verhey F.R., Houx P., Van Lang N., Huppert F., Stoppe G., Saerens J., Bohm L., De Vreese A., Nordlund P.P., DeDeyn M., Neri J., Pena-Casanova A., Wallin E., Bollen H., Middelkoop M.C., Nargeot M., Puel U., Fleischmann M., Jolles J. Cross-national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID). Int. J. Geriatr. Psychiatry 2004, 19(1):41-50.
37. Verhey F.R., Jolles J., Ponds R.W., Rozendaal N., Plugge L.A., de Vet R.C., Vreeling F.W., van de Lught P.J. Diagnosing dementia: a comparison between a monodisciplinary and a multidisciplinary approach. J. Neuropsychiatry Clin. Neurosci. 1993, 5(1):78-85.
38. Visser P.J., Brodaty H. MCI is not a clinically useful concept. Int. Psychogeriatr. 2006, 18(3):402-409. (discussion 409-414).
39. Whitham E.M., Pope K.J., Fitzgibbon S.P., Lewis T., Clark C.R., Loveless S., Broberg M., Wallace A., DeLosAngeles D., Lillie P., Hardy P., Fronsko R., Pulbrook A., Willoughby J.O. Scalp electrical recording during paralysis: quantitative evidence that EEG frequencies above 20Hz are contaminated by EMG. Clin. Neurophysiol. 2007, 118(8):1877-1888.